Live
- Banks must use UPI to create more digital opportunities to empower millions: FM Sitharaman
- Himachal govt to hand over Jangi Thopan Powari hydro project to state power corporation
- Heavy rain forecast for Japan Sea side of northeastern Japan
- Immersive Visual Merchandising: Elevating Brand Storytelling in Retail Spaces
- Heavy Rains Expected in Andhra Pradesh as Low Pressure Forms in Bay of Bengal
- UNWFP to provide emergency food aid to Myanmar flood victims
- JUST CORSECA Launches a Range of Premium Wireless Chargers and Portable Speakers
- Vikram Rathour reunites with Rahul Dravid at Rajasthan Royals
- Travis Head wants to 'keep the chatter' alive on Test opening role
- Rajasthan Atomic Power Project-7 goes critical, to start power generation this year
High intensity ultrasound system for tumor diagnosis, treatment
A Russian firm Shvabe Holding (part of Rostec State Corporation) and Peter the Great St. Petersburg Polytechnic University are working together to create the first Russian equipment for non-invasive tumor treatment.
New Delhi: A Russian firm Shvabe Holding (part of Rostec State Corporation) and Peter the Great St. Petersburg Polytechnic University are working together to create the first Russian equipment for non-invasive tumor treatment.The production of this new high-intensity focused ultrasound (HIFU) system will be organised in the Novosibirsk Instrument-making plant and first prototypes will be created by the end of 2019.
The HIFU system, that includes both hardware and software, will be designed for diagnostics and treatment of tumors in the mammary gland using focused high-intensity ultrasound.
The system will consist of a power module, a medical stand with a monitor and control panel, a robotic manipulator unit, the ultrasound unit with a combined ultrasonic piezoelectric transducer for both diagnostics and treatment and the patient's seat with an immobiliser.
Technical and design development work has already been completed; now the project team is working on the documentation along with system application methods. First prototype of the system will be created by the end of 2019, and first clinical tests could be conducted in 2020.
